The National Science Foundation (NSF) awarded a $274,416 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Biolattice Ophthalmics, Inc. (doing business as Biolattice LLC) on December 1, 2023. The award supports the development of a novel acellular polymer membrane for use as a cornea substitute, with the goal of providing a true alternative to donor cornea for full thickness cornea replacement. The artificial cornea aims to offer a biocompatible, suturable, and optically-clear solution that can be integrated into the patient's eye without the risks and logistical challenges associated with donor cornea tissue. This innovation has the potential to reduce the financial burden of corneal blindness and advance the US medical device manufacturing industry.
Generated 8/13/24, 8:41 AM